Intensity Therapeutics, Inc. Common stock (INTS) is a publicly traded Healthcare sector company. As of July 15, 2026, INTS trades at $4.78 with a market cap of $13.30M and a P/E ratio of -0.57. INTS moved +0.00% today. Year to date, INTS is -52.51%; over the trailing twelve months it is -41.85%. Its 52-week range spans $3.51 to $79.41. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces INTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for INTS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.78 |
| Market Cap | $13.30M |
| P/E Ratio | -0.57 |
| EPS | $-8.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $79.41 |
| 52-Week Low | $3.51 |
| Volume | 11.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.61M |
| Gross Margin | 0.00% |
1 analysts cover INTS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.